Search

everythinglearnresearchcommunity

for

Search:↓

COVID-19 can cause skin issues like rashes and "COVID toes," and people with skin conditions should adjust their treatments if they get the virus.

New insights into the causes and treatments for the autoimmune hair loss condition Alopecia areata have been made.

Fetal cells could improve skin repair with minimal scarring and are a potential ready-to-use solution for tissue engineering.

Patients with chronic skin conditions on systemic treatments did not have worse COVID-19 outcomes and could resume their treatments after recovery.

Immune cells affect hair growth and could lead to new hair loss treatments.

Biologic treatments for Crohn's disease and ulcerative colitis can cause skin problems, and doctors should adjust treatment if these occur.

Epigenetic changes in skin cells contribute to aging, but targeting these changes may offer new antiaging treatments.

Supporting people with alopecia through psychological help and accurate information is crucial for managing stress and coping.

Discoid Lupus Erythematosus often causes scarring hair loss, is influenced by genetics and environment, and requires early treatment to prevent worsening.

Sleep problems and skin issues affect each other; poor sleep can worsen skin conditions, and some skin treatments can improve or harm sleep quality.

Women with acne and irregular periods had higher active testosterone levels, which could suggest the usefulness of antiandrogen treatment.

Chemotherapy caused a woman's permanent hair loss and early menopause.

The method shows hair testosterone levels reflect those in saliva, but are affected by various factors and may indicate a risk for heart attack.

Lupus affects the body and skin, causing joint pain and skin issues that can be treated with steroids and antimalarial drugs.

Psoriasis is a common, genetically influenced skin disease worsened by stress and lifestyle, but targeted treatments are promising.

COVID-19 vaccination is generally safe for people with Hidradenitis Suppurativa.

New treatments for alopecia areata show promise, but standardized guidelines are needed.

Melatonin may help with sleep issues, depression, and cancer, but more research is needed.

Dermal Papilla cells are a promising tool for evaluating hair growth treatments.

New molecules involved in skin and hair growth were identified, improving understanding and future treatments.

New oral treatments for adult hair loss show promise, especially JAK inhibitors, with mild side effects.

Treatment with biologic agents can significantly improve psoriasis symptoms, and blood biomarkers could potentially predict individual patient's response to treatment.

Some patients on immunosuppressants had a weaker immune response to the Sinovac-CoronaVac COVID-19 vaccine.

Dupilumab and ustekinumab are promising treatments for alopecia areata, showing significant hair regrowth.

New treatments for non-small cell lung cancer are being tested, with some already in use, focusing on immune response and targeting cancer cells, but side effects vary.

Baricitinib is the most effective treatment for alopecia areata.

Biologics and targeted therapies could improve treatment for children with certain chronic skin conditions.

Biologics and JAK inhibitors may improve treatment for scarring alopecias.

New biological pathways and potential treatment targets for male pattern baldness were identified.

Managing multiple autoimmune diseases in one patient is very challenging.